Liquidity & Technicals
Liquidity & Technicals
Wise is institutionally tradable with patient execution — ADV of £1.65B and a 5-day capacity of £1.72B at 20% participation make it accessible for funds up to ~£34B at a 5% position weight. The tape is bullish on the 3–6 month horizon: price is above the 200-day SMA, RSI is 69 (strong but not overbought), and the stock is up 24% YTD with a recent golden cross from December 2024 still intact.
5-Day Cap at 20% ADV (£M)
5-Day Cap (% Mkt Cap)
Fund AUM at 5% Wt (£M)
ADV 20d (% Mkt Cap)
Tech Score (+3 to -3)
Constructive tape with adequate institutional liquidity. A 5% position is implementable for funds up to ~£34B at 20% ADV over five days. The stock trades near 52-week highs with strong momentum.
Price Snapshot
Current Price (p)
YTD Return (%)
1Y Return (%)
52W Position (%)
Beta (est)
Full History Price Chart with 50/200 SMA
Price is above the 200-day SMA. The stock is in an uptrend, having recovered from the IPO-to-2022 drawdown (1170p to 340p). The December 2024 golden cross (50 SMA crossing above 200 SMA) remains intact. The death cross in November 2025 noted in the data appears to be a brief dip that was quickly recovered.
Relative Strength
The stock has outperformed the UK broad market (EWU) over 3 years: Wise is up 92% vs EWU's ~25% over the same period. This outperformance has accelerated in 2026, with the stock up 24% YTD vs the UK market's ~8%.
Momentum — RSI & MACD
RSI at 69 is approaching overbought territory (70) but has not triggered. This suggests strong momentum without extreme exhaustion. The recent move from RSI 48 in March to 69 in May confirms the uptrend is backed by buying conviction.
Volume & Volatility
Median daily range over the last 60 days is 1.2% — a manageable execution friction for institutional orders. No zero-volume days.
Institutional Liquidity
ADV 20d (shares)
ADV 20d (£M)
ADV 60d (K shares)
ADV % Mkt Cap
Annual Turnover
A 0.5% of market cap position (~£5.6B) clears in 17 days at 20% ADV. The largest practical 5-day position at 20% participation is ~£1.7B (0.15% of market cap). The US dual listing, if completed, would materially improve liquidity.
Technical Scorecard & Stance
Total: +3 / 6 — Bullish. The tape is constructive. Price is above the 200-day SMA in an established uptrend. Momentum is strong (RSI 69) without being extended. Relative strength is widening versus the UK market. The stock needs to clear 1160p (all-time high / 52-week high) for the next leg up.
Stance: Bullish on the 3–6 month horizon. The uptrend is intact, momentum is strong, and the US dual listing is a potential liquidity and ownership catalyst. Two levels to watch: 1160p above — a breakout above the all-time high would confirm the next uptrend leg and likely trigger institutional inflows. 900p below — a break below the 200-day SMA area would signal the uptrend is over and the stock is rolling over.
Liquidity is manageable but not deep — the correct implementation for a large fund is to build over 2–3 weeks at 10–15% participation, not a 5-day execution. The US listing would resolve this constraint permanently.